General information about company
Scrip code*		544339
NSE Symbol*		LAXMIDENTL
MSEI Symbol*		NOTLISTED
ISIN*		INE0WO601020
Name of company		LAXMI DENTAL LIMITED
Type of company		Main Board
Class of security		Equity
Date of start of financial year		01-04-2025
Date of end of financial year		31-03-2026
Date of board meeting when results were approved		10-02-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange		04-02-2026
Description of presentation currency		INR
Level of rounding		Millions
Reporting Type		Quarterly
Reporting Quarter		Third quarter
Nature of report standalone or consolidated		Consolidated
Whether results are audited or unaudited for the quarter ended		Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended		Unaudited
Segment Reporting		Multi segment
Description of single segment
Start date and time of board meeting		10-02-2026 16:00
End date and time of board meeting		10-02-2026 17:33
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification		Declaration of unmodified opinion

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-10-2025	01-04-2025
Date of end of reporting period		31-12-2025	31-12-2025
Whether results are audited or unaudited		Unaudited	Unaudited
Nature of report standalone or consolidated		Consolidated	Consolidated
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	660.4	2039.03
	Other income	20.77	61.86
	Total income	681.17	2100.89
2	Expenses
(a)	Cost of materials consumed	40	132.91
(b)	Purchases of stock-in-trade	154.42	446.31
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	6.74	24.38
(d)	Employee benefit expense	259.39	753.43
(e)	Finance costs	3.21	10.2
(f)	Depreciation, depletion and amortisation expense	41.7	114.93
(g)	Other Expenses
1	Other Expenses	130.2	383.03
	Total other expenses	130.2	383.03
	Total expenses	635.66	1865.19
3	Total profit before exceptional items and tax	45.51	235.7
4	Exceptional items	-57.79	-57.79
5	Total profit before tax	-12.28	177.91
6	Tax expense
7	Current tax	18.85	61.53
8	Deferred tax	-40.41	-41.57
9	Total tax expenses	-21.56	19.96
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	9.28	157.95
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	10.31	30.29
16	Total profit (loss) for period	19.59	188.24
17	Other comprehensive income net of taxes	0.42	1.62
18	Total Comprehensive Income for the period	20.01	189.86
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent	19.76	188.98
	Total profit or loss, attributable to non-controlling interests	-0.17	-0.74
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	0.42	1.62
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	0	0
21	Details of equity share capital
	Paid-up equity share capital	109.92	109.92
	Face value of equity share capital	2	2
22	Reserves excluding revaluation reserve
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	0.37	3.47
	Diluted earnings (loss) per share from continuing operations	0.36	3.45
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
iii	Earnings per equity share (for continuing and discontinued operations)
	Basic earnings (loss) per share from continuing and discontinued operations	0.37	3.47
	Diluted earnings (loss) per share from continuing and discontinued operations	0.36	3.45
24	Debt equity ratio			Textual Information( 1)
25	Debt service coverage ratio			Textual Information( 2)
26	Interest service coverage ratio			Textual Information( 3)
27	Disclosure of notes on financial results	Textual Information(4)

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-10-2025	01-04-2025
Date of end of reporting period		31-12-2025	31-12-2025
Whether results are audited or unaudited		Unaudited	Unaudited
Nature of report standalone or consolidated		Consolidated	Consolidated
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
1	Laboratory Business	478.27	1423.92
2	Aligners Business	186.52	577.44
3	Other Business	18.77	69.13
	Total Segment Revenue	683.56	2070.49
	Less: Inter segment revenue	23.16	31.46
	Revenue from operations	660.4	2039.03
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
1	Laboratory Business	54.27	229.58
2	Aligners Business	20.64	82.06
3	Other Business	-5.26	-12.67
	Total Profit before tax	69.65	298.97
	i. Finance cost	3.21	10.2
	ii. Other Unallocable Expenditure net off Unallocable income	78.72	110.86
	Profit before tax	-12.28	177.91
3	(Segment Asset - Segment Liabilities)
	Segment Asset
1	Laboratory Business	0	0
2	Aligners Business	0	0
3	Other Business	0	0
	Total Segment Asset	0	0
	Un-allocable Assets	0	0
	Net Segment Asset	0	0
4	Segment Liabilities
	Segment Liabilities
1	Laboratory Business	0	0
2	Aligners Business	0	0
3	Other Business	0	0
	Total Segment Liabilities	0	0
	Un-allocable Liabilities	0	0
	Net Segment Liabilities	0	0
	Disclosure of notes on segments

Other Comprehensive Income
Date of start of reporting period		01-10-2025	01-04-2025
Date of end of reporting period		31-12-2025	31-12-2025
Whether results are audited or unaudited		Unaudited	Unaudited
Nature of report standalone or consolidated		Consolidated	Consolidated
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Amount of items that will not be recalssified to profit and loss	-2.13	-5.96
	Total Amount of items that will not be reclassified to profit and loss	-2.13	-5.96
2	Income tax relating to items that will not be reclassified to profit or loss	-0.53	-1.48
3	Amount of items that will be reclassified to profit and loss
1	Foreign currency translation difference of foreign operations	2.02	6.10
	Total Amount of items that will be reclassified to profit and loss	2.02	6.10
4	Income tax relating to items that will be reclassified to profit or loss	0.00	0.00
5	Total Other comprehensive income	0.42	1.62

Details of Impact of Audit Qualification
Whether results are audited or unaudited		Unaudited
Declaration of unmodified opinion or statement on impact of audit qualification		Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Consolidated results		Yes
	Audit firm's name	Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI	Certificate valid upto
1	M S K A & Associates LLP	Yes	31-07-2027

General information about company

Financial Results – Ind-AS

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Other Comprehensive Income

Details of Impact of Audit Qualification